Autoimmunity to the central nervous system (CNS), especially to myelin basic protein (MBP), may play a causal role in autism, a neurodevelopmental disorder. Because many autistic children harbor elevated levels of measles antibodies, we conducted a serological study of measlesmumps-rubella (MMR) and MBP autoantibodies. Using serum samples of 125 autistic children and 92 control children, antibodies were assayed by ELISA or immunoblotting methods. ELISA analysis showed a significant increase in the level of MMR antibodies in autistic children. Immunoblotting analysis revealed the presence of an unusual MMR antibody in 75 of 125 (60%) autistic sera but not in control sera. This antibody specifically detected a protein of 73–75 kD of MMR. This protein band, as analyzed with monoclonal antibodies, was immuno-positive for measles hemagglutinin (HA) protein but not for measles nucleoprotein and rubella or mumps viral proteins. Thus the MMR antibody in autistic sera detected measles HA protein, which is unique to the measles subunit of the vaccine. Furthermore, over 90% of MMR antibody-positive autistic sera were also positive for MBP autoantibodies, suggesting a strong association between MMR and CNS autoimmunity in autism. Stemming from this evidence, we suggest that an inappropriate antibody response to MMR, specifically the measles component thereof, might be related to pathogenesis of autism.
This is a preview of subscription content, log in to check access.
Buttram HE. Vaccine scene 2000 — Review and update. Med Sentinel 5:49–52;2000.
Chess S, Fernandez P, Korn S. Behavioral consequences of congenital rubella. J Pediatr 93:699–703;1978.
Cohen S, Miller GE, Rabin BS. Psychological stress and antibody response to immunization: A critical review of the human literature. Psychosom Med 63:7–18;2001.
Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol 14:388–394;1999.
Fudenberg HH. Dialyzable lymphocyte extract (DLyE) in infantile onset autism: A pilot study. Biotherapy 9:143–147;1996.
Fujinaga T, Motegi Y, Tamura H, Kuroume T. A prefecture-wide survey of mumps meningitis associated with measles, mumps and rubella vaccine. Pediatr Infect Dis J 10:204–209;1991.
Gupta S, Aggarwal S, Heads C. Dysregulated immune system in children with autism: Beneficial effects of intravenous immune globulin on autistic characteristics. J Autism Dev Disord 26:439–452;1996.
Ivarsson A, Bjerre I, Vegfors P, Ashfors K. Autism as one of several disabilities in two children with congenital cytomegalovirus infection. Neuropediatrics 21:102–103;1989.
Madhur G. Indian scientists warn of ‘mutant measles’ virus. BMJ 322:693;2001.
Menage P, Thibault G, Barthelemy C, Lelord G, Bardos P. CD+ CD45RA+ T lymphocyte deficiency in autistic children: Effect of a pyridoxine-magnesium treatment. Brain Dysfunct 5:326–333;1992.
Plesner AM, Hansen FJ, Taudorf K, Nielsen LH, Larsen CB, Pedersen E. Gait disturbance interpreted as cerebellar ataxia after MMR vaccination at 15 months of age: A follow up study. Acta Paediatr 89:58–63;2000.
Plioplys AV, Greaves A, Kazemi K, Silverman E. Lymphocyte function in autism and Rett syndrome. Neuropsychobiology 29:12–16;1994.
Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity — ‘Vaccinosis’: A dangerous liaison? J Autoimmun 14:1–10;2000.
Singh VK. Plasma increase of interleukin-12 and interferon-gamma: Pathological significance in autism. J Neuroimmunol 66:143–145;1996.
Singh VK. Neuro-immunopathogenesis in autism. In: Berczi I, Gorczynski R, eds. Neuroimmune Biology: New Foundation of Biology. New York, Elsevier Science BV, 447–458; 2001.
Singh VK, Warren RP, Cole P, Odell JD. Abnormalities of interleukin-2 production and levels of IgG isotypes in autistic patients (abstract 1569). FASEB J 3:A496;1989.
Singh VK, Lin SY, Yang VC. Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. Clin Immunol Immunopathol 89:105–108;1998.
Singh VK, Tingle AJ. Detection of circulating immune complexes by a C1q-microplate ELISA system. J Immunol Methods 50:109–114;1982.
Singh VK, Warren RP, Averett R, Ghaziuddin M. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr Neurol 16:88–90;1997.
Singh VK, Warren RP, Odell JD, Cole P, Warren L. Antibodies to myelin basic protein in children with autistic disorder. Brain Behav Immun 7:97–103;1993.
Stubbs EG, Crawford ML, Burger DR, Vanderbark AA. Depressed lymphocyte responsiveness in autistic children. J Autism Child Schizophr 7:49–55;1977.
Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, Berelowitz M, Dhillon AP, Thompson MA, Harvey P, Valentine A, Davies SE, Walker-Smith JA. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351:637–641;1998.
Warren RP, Foster A, Margaretten NC. Reduced natural killer cell activity in autism. J Am Acad Child Adolesc Psychiatry 26:333–335;1987.
Warren RP, Singh VK, Averett RE, Odell JD, Maciulis A, Burger RA, Daniels WW, Warren WL. Immunogenetic studies in autism and related disorders. Mol Chem Neuropathol 28:77–81;1996.
About this article
Cite this article
Singh, V.K., Lin, S.X., Newell, E. et al. Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism. J Biomed Sci 9, 359–364 (2002). https://doi.org/10.1007/BF02256592
- Measles virus
- Measles-mumps-rubella antibodies